In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a ANORO ELLIPTA Drug Master File in Korea (ANORO ELLIPTA KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of ANORO ELLIPTA. The MFDS reviews the ANORO ELLIPTA KDMF as part of the drug registration process and uses the information provided in the ANORO ELLIPTA KDMF to evaluate the safety and efficacy of the drug.
After submitting a ANORO ELLIPTA KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their ANORO ELLIPTA API can apply through the Korea Drug Master File (KDMF).
click here to find a list of ANORO ELLIPTA suppliers with KDMF on PharmaCompass.